[爆卦] 鯊魚可以提煉對抗COVID用的特殊蛋白
正式論文:
https://www.nature.com/articles/s41467-021-27611-y
大意與原理: 研究人員表示,他們發現鯊魚特有的一種蛋白質能夠中和 COVID-19
病毒及其變種。“這些微型的抗體蛋白可以進入人類抗體無法進入的角落和縫隙。
這種稱為 VNAR 的蛋白質是由鯊魚免疫系統自然產生的。它們的大小大約是人類抗體的十分之一,這使得它們足夠小和靈活,可以邊緣化地與傳染性病原體產生的蛋白質結合併停止它們的功能。
在數十億個 VNAR 中,他們發現了三個抗體蛋白對阻止病毒感染人類細胞特別有效。
The COVID-19 pandemic caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has resulted in a devastating global health
crisis. Though vaccines are the centrepiece for controlling the pandemic, thebenefits of vaccines depend upon complex population vaccination strategies
that remain vulnerable to manufacturing or deployment delays. The widely
implemented two-dose requirement to achieve efficacy, leaves the possibility
of non-compliance for the second dose, a situation that may be exacerbated
further by the decision in certain areas to extend the time interval between
dosing. The rapid evolution of SARS-CoV-2 into highly infectious variants
across the globe also has the potential to impact vaccine efficacy.
Researchers have reported that the new SARS-CoV-2 variants can result in
reduced sensitivity to antibody therapies, convalescent plasma, and vaccine
sera1,2,3,4. It has been documented that people with compromised immune
systems respond poorly to COVID-19 vaccines, thus necessitating the
development of additional antiviral therapeutics5,6. As we enter the next keystage in our global escape plan from this pandemic, it is vital to develop
alternative therapeutic approaches and, concurrently, expand our knowledge ofthis virus.
Neutralizing antibody (NAb) therapeutics that block virus entry into the hostcell have demonstrated efficacy at treating COVID-19 infection. Two NAb
therapeutics (LY3819253 and REGN-COV2) received emergency use authorization
status from the Food and Drug Administration for use in the clinic7.
SARS-CoV-2 NAbs target the trimeric spike (S) protein on the viral surface
that mediates cell entry. The S protein has two distinct functional subunits
that facilitate cell attachment (S1) and fusion of the viral and host cell
membranes (S2). The receptor-binding domain (RBD) on the S1 subunit is
responsible for engaging angiotensin-converting enzyme 2 (ACE2)—the cognate
receptor required for membrane fusion. The RBD exists in two different
conformations; the closed “down” conformation and the open “up”
conformation which is highly accessible to ACE2. Studies with NAbs that
target the RBD have revealed mechanisms of viral neutralization based on
changes in the “up” and “down” conformations. In general, NAbs act by
blocking the ACE2 binding interface or by trapping the RBD in the unstable “
up” conformation. Complicating the development of effective NAbs is the
emergence of new SARS-CoV-2 variants with highly mutated S proteins. Studies
have shown that mutational changes in the RBD observed in the variants
correspond to surface-exposed residues within or proximal to the ACE2 bindinginterface. These mutations can result in the modification of NAb epitopes
leading to attenuated or abrogated neutralization of the virus by antibodies.Thus, there is a need for NAbs that can recognize cryptic epitopes
inaccessible to human antibodies that are impervious to mutational drift.
Variable New Antigen Receptors (VNARs) represent an unexplored technology forthe development of next-generation NAbs for SARS-CoV-2. VNARs are the
smallest (~11Da) naturally occurring independent heavy chain-only binding
domains in the vertebrate kingdom. Part of the adaptive immune system of
sharks, VNARs are evolutionarily distinct from immunoglobulins despite
sharing some structural similarity with mammalian heavy and light variable
chains. VNARs further differentiate themselves from classical antibodies and
single-domain camelid antibodies by lacking a CDR2, but possess the benefits
of two additional hypervariable loops (HV2 and HV4), yielding a total of fourloops of diversity into their small and simple domain architecture8. With
characteristic protruding paratopes, the VNARs are pre-disposed to access andbind epitopes not normally available to the planar binding sites of classicalhuman antibodies. This feature allows for the identification of highly potentbinders that reach deep into pockets and grooves within the target
antigen9,10,11. Furthermore, their amenability to reformatting,
cost-effective expression at scale in non-mammalian systems, and exceptional
stability in diverse formulation conditions, makes VNARs ideal for clinical
translation12,13.
Here, we describe the identification and characterization of three monomeric
antiviral VNARs (3B4, 2C02, 4C10) that were found to be potent neutralizers
of pseudotype and authentic SARS-CoV-2 virus. These VNARs were uniquely
potent as monovalent constructs, with efficacies rivalling multimeric
variable-heavy-heavy (VHH) camelid antibodies and Fc-bound bivalent
constructs, including conventional full-length immunoglobulins. The crystal
structures of VNARs 3B4 and 2C02 showed markedly different mechanisms of
neutralization and underscored the likely resilience of VNARs to SARS-CoV-2
variants. Additionally, the VNARs showed neutralization capabilities against
other beta coronaviruses supporting the potential broad therapeutic
application of these VNARs and the VNAR platform against both known diseases
and future emergent disease. Together the three VNARs described here
reinforce the need for the continued expansion of the single-domain
heavy-chain only antibody-like drug class.
--
七魄興輪無上伊甸瑜珈雖然是以看來較為平和的方式以蟬蛻和生乳取代血肉等腥穢之物
作為密義源起供養;然而聚歛於上的是冥界的深冤與大樂奔瀉的淨慈,行者於閉關修持
之時若生起退失動搖之心,則神識旋即離散且肉身消殞;即便如此還是願意受灌頂嗎?
https://imgur.com/cEVD0kE ---妖道七祖《攝一切魔根本瑜珈論/誓命問品第一》---
文章代碼(AID): #1K0Lp7VP (CFantasy) [ptt.cc] Re: [新聞] 湖南偏鄉驚曝百餘......https://imgur.com/eRQKYMF 文章網址: https://tinyurl.com/56ervywe
--
A
A
鯊鯊那麼可愛
鯊鯊 塊陶阿 要被殺掉了
A
我公告圍捕鯊魚大賽開始
A
鯊魚醃好吃
鯊鯊:幹
A
A
Gura要被畢業了
魚翅割完 剩下的肉去做
A
鯊鯊有危險了
幫鯊魚QQ
幫鯊魚qq
A
a
IKEA鯊鯊表示:
RIP
魚翅準備好了
準備絕種了,可憐。
又有正當理由採收魚翅了...可憐的鯊魚
艾莉莎莎小心了
抱歉了鯊魚QQ但人類需要那個cool東西
A
A
A
A
A
要絕種了
A
A
難怪IKEA的鯊魚都消失了......
A
鯊魚拜拜
A
愛莉鯊鯊哭
A
再見了鯊魚
Gura醬嘿嘿嘿
A QQ
A
靠杯,推文一堆A我還以為在西洽
A
鯊鯊 我的超人
A
爆
[外絮] Bane對LBJ的垃圾話所引發的衝突Bane對LBJ的垃圾話所引發的衝突 It takes a lot of courage for any player to talk trash to LeBron James. James is the most accomplished player in the NBA and is a true living legend. And despit e him being 37 years of age, James is playing at an extremely high level and is one of the best players in the league right now.31
Re: [新聞] 莫德納+BNT混打沒邏輯?專家:高端比較好不會是完全一模一樣的蛋白質????????? 現在疫苗不是都S-2P下去玩的嗎???????? 第一步 Google "rna sequence of pfizer moderna vaccine" 第二步 點進去28
[爆卦] 杜蘭大學研究 covid 對靈長類腦部影響Tulane study shows COVID-19’s lingering impacts on the brain April 01, 2022 COVID-19 patients commonly report having headaches, confusion and other neurological symptoms, but doctors don’t fully understand how the disease targets the brain during infection.11
[標的] TLSA 拉回多1. 標的:NASDAQ: TLSA (目前6.99) Tiziana Life Sciences PLC 這不是特斯拉! 這不是特斯拉! 這不是特斯拉!2
Re: [新聞] 自費驗抗體!林氏璧:有屁用?戳破2真美國FDA於今年五月中旬時有發佈一篇文章 大意是不應使用抗體檢驗來判斷一個人是否有新冠保護力 尤其是在接種新冠疫苗之後 ==節錄與翻譯==
2X
Re: [問卦] 真的開戰台灣會很慘吧?爆
Re: [新聞] 我3.4億助立陶宛買工研院晶圓技術 王鴻40
Re: [新聞] 40歲國中女師「結婚6條件」驚退相親男73
[問卦] 真的開戰,美國人要怎麼具體幫台灣啊?77
[問卦] 替代役有到前線作戰的可能性嗎?66
[問卦] 去年吳鳳的果汁6瓶$1099 現在momo5瓶$62954
[爆卦] 台北市中正區又停電啦55
[問卦] 賣大麻關4年換臉關五年?44
[問卦] 幹 股票根本就是賭博阿45
[問卦] 台灣對宏都拉斯的蝦子影響力有那麼大?45
[問卦] 換臉關5年會太重嗎42
[問卦] 台灣從事詐騙的人突然死光會怎樣36
[問卦] 台灣外交現在是不是越來越爛啦36
[問卦] 若iPhone16上市卡關 台灣會花生啥大事?38
[問卦] 日本做麵包加入米奇成分20
[問卦] 13萬嬰兒 養26萬老人有多恐怖?36
[問卦] 驚!也太多台男娶越南女了吧?36
[問卦] 台灣電子菸違法的根本原因是啥?25
[問卦] 為什麼台灣人一定會被送集中營52
Re: [問卦] 京華城為什麼要開在那麼偏僻的地方?32
Re: [新聞]獨家/余苑綺3千萬遺產沒了!爆早被詐騙尪25
[問卦] 海邊魚塭都是太陽能光電板是怎麼回事?27
[問卦] 立陶宛的民主啤酒要怎麼處理32
[問卦] 有餐盒怎麼越做越扁的卦嗎?20
[問卦] 歐美各國學生一一反戰,台灣學生不反戰?28
[問卦] 林依晨是不是看不到許瑋甯的車尾燈了????25
[問卦] 水原一平要關30年 在台灣會關多久?23
[問卦] 日本是怎麼沒落的?24
[問卦] 房貸真的沒人再還完的?總價是假的嗎?23
[問卦] 個股跌爆了 結果大盤才跌31點??